dl- -(4-Cycloaklyl(cyclohexen-1-yl)alkanoic acids and derivatives as antiinflammatory and antiarthritic compounds.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000138:chemical synthesis*; D001168:Arthritis / Q000139:chemically induced / Q000188:drug therapy; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000138:chemical synthesis*; D003516:Cycloparaffins / Q000008:administration & dosage / Q000138:chemical synthesis*; D004487:Edema / Q000188:drug therapy; D005121:Extremities; D006168:Guinea Pigs; D007213:Indomethacin / Q000008:administration & dosage; D007259:Infrared Rays; D008297:Male; D010653:Phenylbutazone / Q000008:administration & dosage; D011830:Radiation Effects; D051381:Rats; D011919:Rats, Inbred Strains; D012867:Skin / Q000528:radiation effects; D013057:Spectrum Analysis; D013329:Structure-Activity Relationship; D014466:Ultraviolet Rays
D000893:Anti-Inflammatory Agents; D003509:Cyclohexanecarboxylic Acids; D003516:Cycloparaffins; D010653:Phenylbutazone; D007213:Indomethacin